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Abstract
Architecture, size, and shape of glands are most important patterns used by pathologists for assessment
of cancer malignancy in prostate histopathological tissue slides. Varying structures of glands along with
cumbersome manual observations may result in subjective and inconsistent assessment. Cribriform gland
with irregular border is an important feature in Gleason pattern 4. We propose using deep neural networks
for cribriform pattern classification in prostate histopathological images. 163708 Hematoxylin and Eosin
(H&E) stained images were extracted from histopathologic tissue slides of 19 patients with prostate cancer
and annotated for cribriform patterns. Our automated image classification system analyses the H&E
images to classify them as either ‘Cribriform’ or ‘Non-cribriform’. Our system uses various deep learning
approaches and hand-crafted image pixel intensity-based features. We present our results for cribriform
pattern detection across various parameters and configuration allowed by our system. The combination of
fine-tuned deep learning models outperformed the state-of-art nuclei feature based methods. Our image
classification system achieved the testing accuracy of 85.93 ± 7.54 (cross-validated) and 88.04 ± 5.63 (
additional unseen test set) across three folds. In this paper, we present an annotated cribriform dataset
along with analysis of deep learning models and hand-crafted features for cribriform pattern detection in
prostate histopathological images.
Keywords: Digital pathology, cribriform pattern detection, deep learning, prostate cancer, transfer
learning.
1 Introduction
The microscopic appearance of prostatic adenocarcinomas is described as having small acini arranged in one
or several patterns. Its diagnosis relies on a combination of tissue architectural structures and cytological
findings. These diagnosis criterion are considered in the Gleason grading system for prostate cancer (PCa).
This grading system is based on the glandular patterns of the tumor and is an established prognostic
indicator [1, 2]. Here, various tissue architectural patterns are identified and assigned a pattern ranging
from 1 (least aggressive) to 5 (most aggressive). Cribriform pattern in malignant glands is one kind of
tissue architecture in prostate, it is one of the important features considered in determining if a tumor
exhibits Gleason pattern 4. Also, it is critical to identify Gleason 3 from Gleason 4 tumor since it changes
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clinical decision. Only Gleason 3 lesions allow active surveillance, instead of subjecting patients to surgery
or radiotherapy.
The Gleason grading system has undergone several modifications over the years [3]. According to several
studies, cases with cribriform glands previously diagnosed as having Gleason pattern 3 would uniformly
be considered grade 4 by today’s contemporary standards [4, 5]. Distinguishing whether a prostatic tumor
exhibit cribriform pattern or not is relevant, since studies have reported that its presence in radical prosta-
tectomy specimens are associated with biochemical recurrence, extraprostatic extension, positive surgical
margins, distant metastases, and cancer-specific mortality [6–10].
Also, Kweldam et al. [10] while studying the prognostic value of individual Gleason grade 4 patterns
among Gleason score 7 PCa patients concluded that cribriform pattern is a strong predictor for distant
metastasis and disease-specific death. The median time to disease-specific death in men with cribriform
pattern was 120 months, as compared to 150 months in men without cribriform pattern. Therefore, proper
recognition of cribriform growth in daily pathology practice could be a useful tool in predicting adverse
clinical outcome in PCa patients.
The Gleason grading system is inherently subjective and hence has led to high intra-observer and inter-
observer variability. Various recent research contributions have suggested that the pathologist’s training
and experience affect the degree of inter-observer agreement [11–13]. Also, diagnosis of PCa by microscopic
tissue examination is tedious and time consuming.
The aforementioned issues of low inter-observer agreement and the requirement of identifying various
types of glandular patterns has motivated research for development of automated image based grading
systems for PCa. Various computer-aided diagnosis (CAD) systems have been developed using a multitude
of machine learning, image processing, and feature extraction methods [14,15]. These systems have usually
automated the task(s) of object detection, image/object classification, and image segmentation for aiding
pathologists. For PCa, CAD systems have generally emphasized on gland segmentation, nuclei segmentation,
and image classification tasks. Cribriform pattern classification is a different task for the conventional PCa
CAD systems and it is yet to get the much needed attention. This paper is an attempt to fill in this gap
by presenting an automated image based cribriform pattern classification system. The main contribution of
this paper are
1. our annotated cribriform dataset,
2. hand-crafted nuclei features, and
3. combination of nuclei features with deep learning (DL) models
for cribriform pattern detection in prostate histopathological images.
These hand-crafted nuclei features are designed to incorporate relevant nuclei texture and spatial in-
formation for cribriform pattern detection. The DL architectures used in our method have been chosen
and/or modified according to their performance in similar histopathological tasks as suggested in liter-
ature [16–22]. Recently, various deep models like ResNet [23], VGG16 [24], VGG19 [24], Inception-v3
(GoogLeNet) [25, 26], and DenseNet [27] have achieved top performance in the ImageNet [28] challenge.
This paper builds upon the recent success of DL in medical images’ tasks [16–21] and robust performance
of ResNet [23], VGG16 [24], VGG19 [24], Inception-v3 (GoogLeNet) [25,26], and DenseNet [27] for the task
of cribriform pattern detection. These DL architectures have been fine-tuned via transfer learning before
combination with hand-crafted nuclei features for cribriform pattern detection. This paper focuses on the
clinical problem of cribriform pattern detection and provides promising machine learning based method to
aid pathologists.
2 Related work
Various CAD systems have been developed for prostate histopathological image classification while au-
tomating gland segmentation, nuclei segmentation, and image classification tasks [14,15,29–43]. Cribriform
pattern classification is an altogether new task for the conventional PCa CAD systems. A general pipeline
for prostate histopathological image classification is gland segmentation followed by feature extraction from
these segmented glands for classification [29–31].
Few approaches like Diamond et al. [35] and Lin et al. [44] have bypassed this segmentation step.
Diamond et al. [35] proposed using morphological and textural features to identify regions belonging to
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stroma, PCa, and normal tissue. Lin et al. [44] used curvelet-based textural features with Support Vector
Machine (SVM) [45] for classifying a given prostate histopathological image as Gleason patterns 3+3, 3+4,
4+3, and 4+4.
Nguyen et al. [30] used shape and textural features to identify nuclei regions. A nuclei-lumen graph made
from nuclei and lumen boundary pixels was processed by normalized cuts [46] for final gland segmentation.
This paper then used various graph based features with SVM [45] for automated PCa grading. Kwak et
al. [31] proposed using multiple scales in the same system for PCa grading. Nuclei, gland and lumen regions
were segmented using features in HSV and CIELab color spaces. For a given image, first the segmentation
was performed and morphological features at multiple scales were used for final automated PCa grading. In
an another similar approach, Ali et al. [43] proposed using nuclei-graphs to compute features for predicting
biochemical recurrence in prostate histopathological tissue microarray images. Fukuma et al. [47] and
Khan et al. [36] also proposed using nuclei graph features for automated grading of brain and prostate
histopathological images respectively.
The methods as discussed above focused on the development of hand-crafted features which are to be
used along with classical machine learning methods. They also focused on a different problem of prostate
histopathological image classification instead of cribriform pattern classification. On similar lines, various
DL architectures have been deployed for prostate histopathological images’ tasks [14,22,33,48,49]. Generally,
DL architectures require a preferably large dataset for training and evaluation purposes due to their huge
parameter space. As manually annotated data in the medical imaging domain is scarce, various recent
research efforts have focused on transfer learning [16, 50–59]. One of the approach for transfer learning
is fine-tuning of pre-trained DL networks. In fine-tuning of pre-trained network, some layers are frozen
during training along with small learning rate. We list out a few recent approaches with the corresponding
pre-trained models used via fine-tuning along with medical image task as follows:
• Shin et al. [16]: Uses GoogLeNet [25] and AlexNet [60] for “Thoracoabdominal Lymph Node Detection”
and “Interstitial Lung Disease Classification”.
• Gessert et al. [51]: Uses ResNet [23], VGG16 [24], and DenseNet [27] for cancer tissue identification
in confocal laser microscopy images for colorectal cancer.
• Khan et al. [52]: Uses VGG16 [24] for brain tumor classification in Magnetic Resonance (MR) images.
• Khan et al. [53]: Uses GoogLeNet [25], ResNet [23], and VGG16 [24] for breast cancer cytological
image classification. They also combined these fine-tuned networks by average pooling.
• Hekler et al. [54]: Uses ResNet [23] for H&E stained melanoma histopathological image classification.
• Brancati et al. [55]: Uses ResNet [23] for invasive ductal carcinoma detection and lymphoma classifi-
cation.
• Ahmad et al. [56]: Uses ResNet [23], GoogLeNet [25], and AlexNet [60] for breast cancer cytological
image classification.
• Hosny et al. [57]: Uses AlexNet [60] for skin lesion image classification.
• Kather et al. [59]: Uses ResNet [23] to predict microsatellite instability in gastrointestinal cancer.
Apart from the latest transfer learning based CAD approaches, various DL architectures have also been
used for breast cancer and lung cancer histopathological images. Coudray et al. [17] trained an Inception-v3
(GoogLeNet) [25,26] on whole slide images (WSI) obtained from The Cancer Genome Atlas to automatically
classify histopathology images into Adenocarcinoma (LUAD), squamous cell carcinoma (LUSC) or normal
lung tissue. Sharma et al. [18] studied H&E stained histopathological images of gastric carcinoma and applied
deep learning to classify cancer based on immunohistochemical response and necrosis detection based on the
existence of tumor necrosis in the tissue. Bejnordi et al. [19] applied deep learning on 2387 H&E stained
breast cancer images to discriminate between stroma surrounding invasive cancer and stroma from benign
biopsies. Gecer et al. [20] proposed an algorithm based on deep convolutional networks that classify WSI of
breast biopsies into five diagnostic categories. Araujo et al. [21] designed a multi-scale deep convolutional
neural network to classify normal tissue, benign lesion, in situ carcinoma, and invasive carcinoma, and in
two classes, carcinoma and non-carcinoma.
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Various recent approaches in machine learning literature have suggested using deeper networks for bet-
ter classification/detection performance [23, 27]. Following which, various deep models like ResNet [23]
and DenseNet [27] have achieved top performance in the ImageNet [28] challenge. These networks have
outperformed the previous top performer GoogLeNet [25]. On the other hand, medical images with their
heterogeneous patterns has warranted need of a more sophisticated DL model when compared to natural
images. This paper builds upon the recent success of DL in medical images’ tasks and top performance of
ResNet [23] and DenseNet [27] for the task of cribriform pattern classification. These two networks have been
compared with SVM classifier which used nuclei based features [33, 36, 47], VGG16 [24], VGG19 [24], and
Inception-v3 (GoogLeNet) [25, 26]. The VGG16 [24], VGG19 [24], and Inception-v3 (GoogLeNet) [25, 26]
are some of the initial DL architectures which achieved high performance across large scale natural image
datasets. In this paper, the performance of ‘ResNet-50’ which is ResNet [23] network with 50 layers along
with ‘DenseNet-121’, ‘DenseNet-169’ which are DenseNet [27] networks with 121 and 169 layers respectively
are studied for the task of cribriform pattern detection. All these DL architectures have been fine-tuned
via transfer learning. The fine-tuned DL architectures are then combined with hand-crafted nuclei features
using Multi-layer Perceptron (MLP) for our final results. This paper focuses on the clinical problem of
cribriform pattern detection and provides promising machine learning based method to aid pathologists.
3 Dataset
3.1 Dataset preparation
H&E stained whole slide images were downloaded from the ‘Legacy Archives’ of the NCI Genomic Data
Commons (GDC) [61]. The GDC Legacy Archives currently hosts much of “The Cancer Genome Atlas
(TCGA)” [62] data. The TCGA has various WSIs categorised according to cancer types. Each WSI has
a unique patient ID (Slide Name) in TCGA. This patient information is important when we design the
experiments. The design should be such that patients sets among training, testing, and validation sets are
mutually exclusive for reliable experiments and results.
Cribriform pattern may be seen in both benign and malignant glands. Neoplastic cribriform gland
pattern may be seen in high grade prostate intraepithelial neoplasia (HG-PIN), acinar adenocarcinoma
Gleason pattern 4, intraductal carcinoma of the prostate (IDC-P), and prostatic duct adenocarcinoma. Some
example images for both ‘Cribriform’ and ‘Non-cribriform’ patterns are illustrated in Fig. 1. Cribriform
patterns are characterized by solid proliferation with multiple punched-out lumina, without intervening
stroma [10] as evident in the first row of Fig. 1.
Cribriform Patterns
Non-cribriform Patterns
Figure 1: Example H&E images with ‘Cribriform’ and ‘Non-cribriform’ patterns in our dataset. These images
were extracted at 40× magnification with pixel resolution of 0.25MPP. The cribriform pattern detection
system was developed using H&E images with different color variations.
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Usual approach of data preparation is a pathologist going through the WSI using Aperio ImageScope [63]
and then extract images containing regions of interest(ROIs). These ROIs will either contain a cribriform
pattern or a Non-cribriform pattern and hence labelled accordingly. We followed this protocol and initially
extracted 161 images (1024 × 1024 pixels) at 40× from WSI of 10 patients using Aperio ImageScope [63].
The 1024 × 1024 pixels dimension was chosen by the pathologist such that the corresponding field of view
contained enough information to identify if the image contains a cribriform pattern or not. The subsequent
experiments for cribriform detection using deep learning were inconclusive due to insufficient patient data.
We then extracted 3072 × 3072 pixels images from 9 more patients using Aperio ImageScope [63] and
OpenSlide [64]. These images were then annotated by the pathologists in our team as ‘Cribriform’ or ‘Non-
cribriform’. Table 1 tabulates the number of manually extracted and annotated images from each patient.
This way we extracted 728 labeled images from 19 patients. Apart from these labeled images there were
some images which were rejected during the labelling process as they were ambiguous and/or tissue structure
was not preserved well.
After manually going through the images with the pathologist for labelling individual images we aug-
mented the data using translation and rotation operations. The following section describes the data aug-
mentation process.
Table 1: Description of the manually extracted and annotated images in the cribriform dataset. We
have 12 unique cribriform and 7 unique non-cribriform patients.
S.N. Slide Name
(Patient ID)
Gleason grade Number of
Cribriform
Images
Number
of Non-
cribriform
Images
Image Dimen-
sions
1 TCGA-2A-A8VO 3+3 (HG-PIN) - 17 1024× 1024 pixels
2 TCGA-2A-A8VT 3+3 (HG-PIN) 2 - 1024× 1024 pixels
3 TCGA-EJ-5510 4+3 (HG-PIN) 6 1 1024× 1024 pixels
4 TCGA-EJ-5511 3+4 (HG-PIN) 1 16 1024× 1024 pixels
5 TCGA-EJ-5519 4+4 (HG-PIN) 5 - 1024× 1024 pixels
6 TCGA-EJ-7797 3+4 (HG-PIN) - 21 1024× 1024 pixels
7 TCGA-G9-6338 4+3 (No HG-PIN) - 36 1024× 1024 pixels
8 TCGA-G9-6363 4+3 (HG-PIN) - 14 1024× 1024 pixels
9 TCGA-HC-7211 3+4 (HG-PIN) 25 - 1024× 1024 pixels
10 TCGA-HC-7212 3+4 (HG-PIN) 17 - 1024× 1024 pixels
11 TCGA-EJ-7791 No report 1 51 3072× 3072 pixels
12 TCGA-EJ-8469 4+5 (HG-PIN) 121 - 3072× 3072 pixels
13 TCGA-EJ-A46F 4+4 (HG-PIN) 86 - 3072× 3072 pixels
14 TCGA-FC-7708 No report 5 60 3072× 3072 pixels
15 TCGA-HC-7078 No report 1 12 3072× 3072 pixels
16 TCGA-HC-7820 3+4 (HG-PIN) - 9 3072× 3072 pixels
17 TCGA-XJ-A9DI 5+4 (No HG-PIN) - 28 3072× 3072 pixels
18 TCGA-XK-AAJP 4+3 (HG-PIN) - 80 3072× 3072 pixels
19 TCGA-YL-A8HL 4+5 (No HG-PIN) 114 - 3072× 3072 pixels
Total 1024× 1024 pixels images from 10 patients 56 105
Total 3072× 3072 pixels images from 9 patients 328 240
Total (749 images from 19 patients) 384 365
3.2 Data augmentation
We augment the dataset by using translation, rotation based sampling in the WSI. Given that we know the
location of extracted 1024 × 1024 and 3072 × 3072 pixels images in the WSI, we can extract a region of
around 5000×5000 pixels around it using OpenSlide [64]. In this extracted region we can sample new images
by translation of 50-100 pixels to the left, right, top, bottom of from the position of original image. Apart
from translation, we can also sample images by rotation with and without translation. Fig. 2 illustrates the
idea this idea for data augmentation. The images which are extracted around a given unique location will
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have same label as the original image location.
Let us define the total number of rotation, translations for extraction of new images. This will aid us in
estimating the size of the augmented dataset. We define the translations of 50(= ∆) and 100(= 2∆) pixels
along the horizontal (X-axis) and vertical (Y-axis) directions as two possible operations. We also define the
rotation operations of 60◦ and 120◦ for a given image.
So, from original image location of (xc, yc) we can have combinations of (xc ± k∆, yc ± k∆) where
k ∈ {0, 1, 2}. These translation operations will give us 25 = (5 × 5) times the original images. The two
rotation operations will give us 3 times the images. Eventually, one original image will give us 75(= 5×5×3)
images.
Figure 2: Example of extraction of new images from Whole Slide Image (WSI). A WSI is indicated as
an arbitrary structure filled with green. The originally extracted 1024 × 1024 pixels image is indicated by
a filled red box. The surrounding 5000 × 5000 pixels region is indicated by blue bordered box filled with
white. The new images are to be sampled from inside this region. Some of the sampled images after rotation
and/or translation from the original image are indicated by black empty boxes. Translation can be done by
50 and 100 pixels in horizontal and vertical directions from a given image. From original location of (xc, yc)
to (xc± k∆, yc± k∆) locations where k ∈ {0, 1, 2} and ∆ = 50. We can extract more images after rotations
of 60◦ and 120◦ from a given image location. This will give us 75(= 5× 5× 3) times the original dataset of
images.
The originally extracted images were augmented using the method described above. The images were
then checked manually for areas with empty regions which appear due to rotation and translation into empty
WSI area. We have removed these images and then sorted all the remaining images which we extracted
according to patient and label. There are 53557 ‘Cribriform’ and 110151 ‘Non-cribriform’ images after
augmentation. This way we have a total of 163708 images (1024 × 1024 pixels) from 19 TCGA patients.
Table 2 tabulates the patient wise number of images in the augmented dataset.
As the total number of images in the augmented dataset is quite big, we used a subset of images for our
experiments. We have defined three sets of patients for a three-fold cross-validated study such that patients
for training, validation, and testing images are mutually exclusive. This configuration is to mimic the real
world scenario for deployment of any cribriform pattern classification system. Table 3 tabulates these sets
along with their use during the three folds. We sampled 1500 Cribriform (+ve), 1500 Non-cribriform (-ve)
images in each of these sets for use in our experiments. This way we have a balanced dataset in our studies.
We also defined an additional unseen test set for further evaluating our models. This additional unseen test
set contains the images which have never been used for training, validation, and testing in the three-fold
cross-validated study. The patients in the additional unseen test set and the test set in the cross-validated
study for a given fold are the same. The addition unseen test set also contains 1500 Cribriform (+ve) and
1500 Non-cribriform (-ve) images in each fold ( three folds, same as the cross-validated study).
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Table 2: Description of the all images in the augmented cribriform dataset. We have 12 unique cribriform
and 7 unique non-cribriform patients. These images are of 1024× 1024 pixels.
S.N. Slide Name
(Patient ID)
Gleason grade Number of
Cribriform
Images
Number
of Non-
cribriform
Images
1 TCGA-2A-A8VO 3+3 (HG-PIN) - 1292
2 TCGA-2A-A8VT 3+3 (HG-PIN) 152 -
3 TCGA-EJ-5510 4+3 (HG-PIN) 456 76
4 TCGA-EJ-5511 3+4 (HG-PIN) 76 1216
5 TCGA-EJ-5519 4+4 (HG-PIN) 380 -
6 TCGA-EJ-7791 No report 76 21201
7 TCGA-EJ-7797 3+4 (HG-PIN) - 1596
8 TCGA-EJ-8469 4+5 (HG-PIN) 24000 -
9 TCGA-EJ-A46F 4+4 (HG-PIN) 10594 -
10 TCGA-FC-7708 No report 379 29935
11 TCGA-G9-6338 4+3 (No HG-PIN) - 2736
12 TCGA-G9-6363 4+3 (HG-PIN) - 1064
13 TCGA-HC-7078 No report 20 5188
14 TCGA-HC-7211 3+4 (HG-PIN) 1900 -
15 TCGA-HC-7212 3+4 (HG-PIN) 1292 -
16 TCGA-HC-7820 3+4 (HG-PIN) - 3943
17 TCGA-XJ-A9DI 5+4 (No HG-PIN) - 11699
18 TCGA-XK-AAJP 4+3 (HG-PIN) - 30185
19 TCGA-YL-A8HL 4+5 (No HG-PIN) 14233 -
Total (163708 images from 19 patients) 53557 110151
Table 3: Set of patients in the three-fold cross-validated study. We sampled 1500 Cribriform (+ve), 1500
Non-cribriform (-ve) images in each of these sets for use in our experiments.
Set 1 Set 2 Set 3
Fold 01: Train; Fold 01: Validation; Fold 01: Test;
Fold 02: Validation; Fold 02: Test; Fold 02: Train;
Fold 03: Test; Fold 03: Train; Fold 03: Validation;
• TCGA-2A-A8VT,
• TCGA-HC-7212,
• TCGA-FC-7078,
• TCGA-YL-A8HL,
• TCGA-XJ-A9DI,
• TCGA-XK-AAJP.
16056 Cribriform (+ve),
71839 Non-cribriform (-
ve)
• TCGA-2A-A8VO,
• TCGA-EJ-7791,
• TCGA-EJ-7797,
• TCGA-HC-7211,
• TCGA-EJ-5519,
• TCGA-G9-6363,
• TCGA-EJ-A46F.
12949 Cribriform (+ve),
25153 Non-cribriform (-
ve)
• TCGA-HC-7708,
• TCGA-HC-7820,
• TCGA-EJ-5510,
• TCGA-G9-6338,
• TCGA-EJ-5511,
• TCGA-EJ-8469.
24552 Cribriform (+ve),
13159 Non-cribriform (-
ve)
1500 Cribriform (+ve),
1500 Non-cribriform (-
ve)
1500 Cribriform (+ve),
1500 Non-cribriform (-
ve)
1500 Cribriform (+ve),
1500 Non-cribriform (-
ve)
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4 Methods
We have studied nuclei feature based classical machine learning model along with fine-tuned deep learning
models for cribriform pattern detection. The classical machine learning model act as a base-line method for
our system. We discuss all the methods for cribriform pattern detection in following sections.
4.1 Nuclei features with SVM
Various image based automated PCa grading studies have suggested using local and global features derived
from nuclei patterns [33,36,43,47]. Most commonly used local features quantify intensity distribution, radial
intensity distribution, etc inside the segmented nuclei objects. These studies have also suggested creating
nuclei graphs to quantify nuclei spatial distribution as a global feature. These nuclei based features with
SVM are used as a base-line method for cribriform pattern detection experiments.
Given a nuclei segmentation, a digraph G can be defined whose vertices are the centroids of the segmented
nuclei [47]. G is a complete digraph with edges weighted according to euclidean distance between the vertices
(centroids). The nuclei spatial distribution was then quantified by computing Delaunay Triangulation and
Minimum Spanning Tree (MST). The Delaunay Triangulation for the vertices in G was computed using the
Triangle software [65]. The triangle area and perimeter based sub-features are extracted from this Delaunay
Triangulation. The MST for G was also computed using Kruskal’s algorithm [66]. For a given MST, its
corresponding edge weight distribution was quantified as a sub-feature. Both of these sub-features constitute
the image level nuclei feature.
The CellProfiler [67] pipeline suggested by Fukuma et al. [47] has been used for nuclei segmentation and
feature extraction. Fig. 3 shows the modules used in the CellProfiler [67] pipeline. Fig. 4(a) shows a sample
input H&E image for the CellProfiler [67] pipeline. Fig. 4(b) shows the segmented nuclei locations as red
diamonds on white background. These nuclei locations are used to define G. These segmented nuclei regions
are also used to extract nuclei level features like intensity distribution, eccentricity, etc. The MST features
are extracted using the vertices in G. Fig. 4(c) shows the Delaunay Triangulation using the vertices in G.
Table 4 discusses these features in detail. This table also details which tool or algorithm or CellProfiler [67]
module was used for the given nuclei sub-feature extraction.
Kwak et al. [33] illustrated that the RBF kernel SVM performs better then polynomial kernel SVM for
the above nuclei features. Following this idea, the C and γ for the RBF kernel were fine-tuned first and
then fixed as C = 100 and γ = 0.1 for final experiments.
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ColorToGray
Smooth
EnhanceOrSupressFeatures
ApplyThreshold
IdentifyPrimaryObjects
ConvertObjectToImage
MeasureObjectIntensityDistribution
MeasureObjectSizeShape
MeasureObjectIntensity
ExportToSpreadsheet
H&E Image
Features and Nuclei Segmentation
Figure 3: Modules used in the CellProfiler [67] pipeline for nuclei segmentation. This pipeline has been
implemented as proposed by Fukuma et al. [47].
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(a) (b) (c)
Fig 4: (a) Example input H&E image. (b) Segmented nuclei locations are indicated in red di-
amonds. Graph G is defined using these nuclei locations. (c) Delaunay Triangulation using the
vertices of graph G.
17
Figure 4: Intermediate stages during nuclei feature generation for an input H&E image using CellProfiler [67]
and Delaunay Triangulation. (a) Example input H&E image. (b) Segmented nuclei locations are indicated
in red diamonds (By CellProfiler [67]). Graph G is defined using these nuclei locations. (c) Delaunay
Triangulation using the vertices of graph G. Table 4 discusses these features in detail.
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4.2 Fine-tuning of pre-trained DL architectures
The extracted images at 1024×1024 pixels dimensions were used for experiments with fine-tuning of different
state-of-art DL architectures. These state-of-art DL architectures have been pre-trained on the ImageNet
dataset [28]. Fine-tuning was done in two stages as follows:
1. The last layers of each pre-trained network were modified for the cribriform pattern classification
(binary classification). All the layers except the last fully connected layers in the modified network
were frozen (non-trainable) for the first stage. The modified network was trained for 100 epochs.
2. In the second stage the last block before the fully connected layers in the modified network was set as
trainable. In this second stage, the last block along with the fully connected layers were trained for
100 epochs.
For both of the above stages, the learning rate was kept low to prevent overfitting due large number of
trainable parameters with the given small amount of training images. The two stage fine-tuning strategy
has been borrowed from the online Keras [68] tutorial “Building powerful image classification models using
very little data” [69]. This tutorial used TensorFlow [70] as a back-end for deep learning.
Another possible strategy for fine-tuning is skipping first stage and directly fine-tune at the second stage
itself. This way one will get non-reliable results because the random initialisation (high entropy) of last fully
connected layers will induce massive change in weights in the last block of the network. The first stage in
the above used strategy essentially reduces the entropy in the last fully connected layer leading to reliable
results.
4.3 Fine-tuning of pre-trained and modified ResNet architectures
Additionally, we fine-tuned ResNet-50 [23, 71] and ResNet-22, whereby we replaced the output layer of
ResNet with two output nodes and kept all previous layers untouched. We separated the whole fine-tuning
procedure into two stages. In the first stage, only the last layer was fine-tuned which runs for 13
rd
of the
total number of epochs. For the second stage which runs for 23
rd
of the total number of epochs, the last
ResNet block was trained as well as the output layer. In ResNet, all blocks are a bottle-neck block that
consists of 3 convolutional layers.
ResNet-22 is a modified version of ResNet-50 [23] whose structure is basically the first 21 layers of
ResNet-50 [23] plus a fully-connected layer at the output. The main advantage of using ResNet-22 is
that it has a fewer number of parameters while still maintaining the powerful capabilities of the original
ResNet [23] architecture. The input size is 256× 256, whereby each image has three channels, namely R, G,
and B. Architecture comparisons between the ResNet-50 and ResNet-22 network architecture are tabulated
in Table 5. Both models share the same architecture for the first 21 layers as shown in Table 5 at the first
four rows.
4.4 Feature combination using Multi-Layer Perceptron (MLP)
Kallen et al. [38] proposed using OverFeat [72] network for feature extraction from prostate H&E images.
These features were then fed into an SVM for automated PCa grading. During the experiments with nuclei
features and various deep learning models some scope of improvement for cribriform pattern detection was
observed. Subsequently, these methods were combined using feature concatenation and training a Multi-
Layer Perceptron (MLP). Following a similar approach to Kallen et al. [38] features from a given image were
extracted and then used to fine-tune the pre-trained ‘ResNet’, ‘DenseNet’, and ‘Inception-v3’ models.
In the MLP, the 57 nuclei features are concatenated with features from all “VGG’,‘ResNet’, ‘DenseNet’,
and ‘Inception-v3’ models trained upon 256× 256, 128× 128, 64× 64, 32× 32, and 16× 16 pixels images.
The two hidden layers in this MLP has 512 and 128 nodes respectively. This MLP was trained for 10, 000
epochs. We achieved testing accuracy of 85.93 ± 7.54 across three folds.
5 Results
Several DL models and nuclei features based model were assessed for effectiveness using the augmented
cribriform image (balanced) dataset. The H&E images in the dataset were downscaled to 256×256, 128×128,
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Table 5: Comparison between the network architectures of ResNet-50 [23] and ResNet-22. Each [] means
one residual block. For example, in the fourth row we used 4 residual blocks where each residual block
consists of 1 ×1 convolution followed by 3× 3 and then 1× 1. Because ResNet-22 duplicates only the first
21 layers of ResNet-50 [23], the sixth and the seventh row has ‘No Operation’.
Output Size ResNet-50 [23] ResNet-22
262 × 262 1×1, 64, stride 2
63 × 63 3×3, Max-Pool , stride 2
63 × 63
 1× 1, 643× 3, 64
1× 1, 256
× 3
16 × 16
1× 1, 1283× 3, 128
1× 1, 512
× 4
16 × 16
 1× 1, 2563× 3, 256
1× 1, 1024
× 6 No operation
8 × 8
 1× 1, 5123× 3, 512
1× 1, 2048
× 3 No operation
1 × 1 Average Pool, 2-D, Full-Connected, Softmax
64× 64, 32× 32, and 16× 16 pixels for fine-tuning and testing of all DL models. The nuclei feature based
SVM was trained and evaluated with images downscaled to 256×256 pixels. The Keras [68] based framework
resizes the input images to the internal image dimension of the given DL network. For example, ‘ResNet-50’
uses ‘224 × 224’ pixels input image resolution. Given an input image of 256 × 256 pixels, it is resized to
224× 224 pixels and then fed into the network during training and testing. The same process is used for all
the DL models with different input image sizes (scales).
Three-fold cross-validated study was done such that patients for training, validation, and testing images
are mutually exclusive to mimic the real world scenario for a cribriform pattern classification system. As
discussed before in section 3.2, we had also defined an additional unseen test set for further evaluating our
models. We expect the trained models to perform similarly during testing in both of the cross-validated
study and the additional unseen test set. We tested the top three performing individual DL models on this
additional unseen test set across the three folds.
Table 6 tabulates the testing accuracy for nuclei feature based methods along with fine-tuned DL ar-
chitectures in the three-fold cross-validated study and for the top three models on the additional unseen
test sets. The results for the top three models in the three-fold cross-validation study and on the additional
unseen test set were similar. The experiments were conducted in two separate locations. The nuclei fea-
ture based method along with fine-tuned DL architectures were evaluated at first location. The modified
ResNet [23] was designed and implemented in second location. The implementations were shared across
the locations to validate reproducibility. For reproducibility checks, the DL experiments were done using
300 images on both locations. The results on both locations were identical. First experiment location used
Ubuntu 14.04 64bit desktop with 32GB RAM, Intel i7 3.5 GHz CPU, and 6GB Nvidia TITAN GPU. The
second location used Ubuntu 16.04 64bit desktop with 64 GB RAM, Intel i7 3.4 GHz CPU, and 12 GB
Nvidia Titan X GPU.
5.1 Performance of DL models
Given the images rescaled to different resolutions from same image, the amount of usable information is
directly proportional to the resolution of the rescaled image. We studied the performance from 256 × 256
to 16× 16 pixels, the test accuracy decreases with image resolution which is as per our expectations.
VGG16 [24], VGG19 [24], and Inception-v3 [25, 26] were the top performers while newer and more
complex architectures ResNet-50 [23], DenseNet-121 [27], and DenseNet-169 [27] did not perform well. This
indicates that DL architectures, with low number trainable parameters (low model complexity) performed
better than the DL architectures with much higher number of trainable parameters(high model complexity).
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This results can be attributed to the fact that the highly complex DL architectures will need higher number
of training data samples. The same results were observed when ResNet-22 was designed after modifying
ResNet50 [23].
The additional unseen test set results for our top three performing models VGG16 [24], VGG19 [24],
and Inception-v3 [25, 26] were similar to the three-fold cross-validated study results. This further confirms
their robust performance. Also, in some of our trained/fine-tuned models, we observed that standard error
of testing accuracy is a bit high indicating variable model performance across three folds. This can be
attributed to the low number of patients being used for training. The models performance will improve with
more patient information.
6 Conclusion
Pre-trained ‘VGG16’, ‘VGG19’, ‘ResNet-50’, ‘DenseNet-121’, ‘DenseNet-169’, and ‘Inception-v3’ were fine-
tuned and tested to assess the possibility of using transfer learning for cribriform pattern detection. The
performances of these models in their individual and combined capacity were assessed. Various hand-crafted
nuclei features were also designed and tested for cribriform pattern detection. Some of these nuclei feature
has been successful in prostate cancer grading which is easier problem when compared to cribriform pattern
detection. Cribriform patterns are one of patterns in high grade prostate cancer regions. Our Non-cribriform
labelled images include various high grade PCa regions which appear similar to cribriform pattern w.r.t.
nuclei texture and clustering. The fine-tuned DL models were able to correctly identify cribriform pattern
as they were able to use the information not limited to just nuclei texture and location. The detection
results at various scales using DL models were analysed and combined with nuclei features using MLP with
improved performance. The cribriform detection results are promising and can be treated as a base-line
for future projects. The current dataset includes images from Gleason pattern 3, Gleason pattern 4, and
HG-PIN regions with color variations. Future studies should include cribriform pattern images from all
possible sources and various color variations encompassing multiple patient information.
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Table 6: Testing Accuracy for various methods. Reported values are average ± standard error across
the three folds. VGG16 [24], VGG19 [24], Inception-v3 [25, 26], and combination of all DL methods along
with nuclei features using MLP achieve best results (Indicated in bold).
Method Input image dimensions
(RGB), Scale
Testing Accuracy (%age),
Testing accuracy on addi-
tional unseen set (if appli-
cable in %age)
‘ResNet-22’: 256× 256 pixels. 256× 256 pixels, 1:1 73.33 ± 16.66
‘VGG16’ [24]:
224× 224 pixels.
256× 256 pixels, 1:1 85.65 ± 6.68, 85.81 ± 6.74
128× 128 pixels, 1:2 81.08± 4.58
64× 64 pixels, 1:4 72.33± 6.19
32× 32 pixels, 1:8 56.08± 7.23
16× 16 pixels, 1:16 75.46± 7.73
‘VGG19’ [24]:
224× 224 pixels.
256× 256 pixels, 1:1 86.78 ± 6.97, 86.25 ± 7.18
128× 128 pixels, 1:2 83.76± 9.47
64× 64 pixels, 1:4 81.10± 7.54
32× 32 pixels, 1:8 50.14± 0.18
16× 16 pixels, 1:16 73.92± 11.28
‘Inception-v3’ [25,26]:
299× 299 pixels.
256× 256 pixels, 1:1 88.18 ± 5.99, 88.04 ± 5.63
128× 128 pixels, 1:2 84.37± 8.22
64× 64 pixels, 1:4 82.37± 9.78
32× 32 pixels, 1:8 79.83± 8.88
16× 16 pixels, 1:16 80.84± 9.38
‘DenseNet-121’ [27]:
224× 224 pixels.
256× 256 pixels, 1:1 73.48± 9.76
128× 128 pixels, 1:2 65.20± 10.8
64× 64 pixels, 1:4 63.02± 7.93
32× 32 pixels, 1:8 63.74± 13.86
16× 16 pixels, 1:16 59.64± 10.75
‘DenseNet-169’ [27]:
224× 224 pixels.
256× 256 pixels, 1:1 64.91± 6.33
128× 128 pixels, 1:2 67.12± 11.26
64× 64 pixels, 1:4 61.65± 7.45
32× 32 pixels, 1:8 54.67± 3.01
16× 16 pixels, 1:16 56.78± 4.23
‘ResNet-50’ [23]:
224× 224 pixels.
256× 256 pixels, 1:1 53.45± 5.03
128× 128 pixels, 1:2 50.64± 0.78
64× 64 pixels, 1:4 57.03± 15.86
32× 32 pixels, 1:8 52.48± 1.30
16× 16 pixels, 1:16 53.89± 4.68
RBF kernel SVM (C = 100, γ =
0.1) using nuclei features (described
in Table 4).
256× 256 pixels, 1:1 44.39± 21.55
Combination of nuclei features with
DL features using MLP (Not includ-
ing ResNet-22)
All scales from 256×256 pixels
to 16× 16 pixels.
85.93 ± 7.54
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